Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened ... took to social media to defend the FDA’s controversial handling ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

The Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.